Page last updated: 2024-08-22

vanadates and inno-406

vanadates has been researched along with inno-406 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, ZS; Patel, BA; Talele, TT; Wang, YJ; Yang, DH; Zhang, GN; Zhang, YK	1

Other Studies

1 other study(ies) available for vanadates and inno-406

Article	Year
Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters. Scientific reports, 2016, 05-09, Volume: 6 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Fluorescence; Humans; Mitoxantrone; Mutation; Paclitaxel; Pyrimidines; Time Factors; Vanadates	2016

Article

Year

Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters.

Scientific reports, 2016, 05-09, Volume: 6

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Fluorescence; Humans; Mitoxantrone; Mutation; Paclitaxel; Pyrimidines; Time Factors; Vanadates

2016